Managed Care Pharmacy (PBMs): What Do Pharmacists at Insurance Companies Do? A Look at Formulary Management and Prior Authorizations

Managed Care Pharmacy (PBMs): What Do Pharmacists at Insurance Companies Do? A Look at Formulary Management and Prior Authorizations

by

Many people picture pharmacists behind a counter. But a large number work at health plans and pharmacy benefit managers (PBMs). Their job is to make sure the right medicines are covered, used safely, and bought at a fair price. This article explains what these pharmacists do, focusing on formulary management and prior authorizations. You will see how decisions are made, why rules exist, and how to work with the system.

Where Managed Care Pharmacists Work

Managed care pharmacists work at health insurers, PBMs, employer coalitions, and integrated health systems. They collaborate with physicians, nurses, actuaries, data analysts, and finance teams. The goal is simple: pay for effective drugs, reduce avoidable harm, and keep premiums affordable. Every coverage decision affects real people, so these teams balance evidence, safety, and cost every day.

Formulary Management: How Drugs Make the List

A formulary is the plan’s list of covered drugs and rules for using them. Pharmacists lead the work, but decisions run through an independent Pharmacy & Therapeutics (P&T) Committee. This group includes physicians and sometimes patient representatives. Here is what they evaluate:

  • Clinical efficacy: How well does the drug work compared to current options? They look at clinical trials and real-world studies.
  • Safety: Side effects, drug interactions, black box warnings, and long-term risks.
  • Appropriate use: Dosing, route (pill, injection), and who benefits most.
  • Value for money: The net price after rebates, and the expected health impact per member.
  • Unmet need: Does the drug help patients who have no good alternatives?

Why this process matters: not every new drug offers better outcomes. Some add small benefits at high cost or carry new risks. The formulary pushes coverage toward drugs that work best for the average patient in a class. This protects patients from ineffective or unsafe use and steers spending to treatments that deliver more health per dollar.

Designing Tiers, Restrictions, and Step Therapy

Formularies use tiers to guide choices:

  • Tier 1: Low-cost generics.
  • Tier 2: Preferred brand drugs (usually best net cost in their class).
  • Tier 3+: Non-preferred brands or specialty drugs with higher copays.

Some drugs come with rules. Common ones include:

  • Quantity limits: Safe dosing and waste control (for example, 9 migraine tablets per month).
  • Age or diagnosis limits: Ensure the drug is used for the right condition.
  • Step therapy: Try a proven, lower-cost therapy first unless medically inappropriate.

Examples:

  • Diabetes: Metformin is first-line. Newer drugs (like GLP-1 agonists) may be preferred after metformin failure or when weight loss or cardiovascular benefit is a priority.
  • Migraine: A CGRP inhibitor may require trying a triptan first, unless triptans are unsafe (e.g., coronary disease).
  • Cholesterol: PCSK9 inhibitors often require documented statin use or intolerance and high LDL despite therapy.

Why restrictions exist: they nudge use toward therapies with strong evidence and better affordability, while still allowing exceptions for unique clinical needs.

Utilization Management and Prior Authorization Criteria

Utilization management (UM) keeps use safe and appropriate. Prior authorization (PA) is the most visible UM tool. PBM pharmacists write the criteria using:

  • FDA labeling and safety warnings.
  • Clinical guidelines from medical societies.
  • Comparative studies and expert consensus.
  • Plan policy and legal requirements.

Each PA includes specific requirements, such as:

  • Diagnosis confirmation: ICD-10 codes, chart notes, or test results.
  • Clinical severity: For example, asthma exacerbations or A1C level.
  • Treatment history: Which drugs were tried, for how long, and what happened.
  • Safety checks: Lab values, contraindications, dosing limits.

Not all PAs are the same. Some are clinical (checking medical need), while others are administrative (confirming coverage under the correct benefit, e.g., pharmacy vs medical). Pharmacists maintain these criteria and update them as new evidence or safety alerts appear.

How a Prior Authorization Moves Through the System

Here is the typical path:

  1. Submission: The prescriber or their staff sends a request via ePA (electronic PA) or fax, answering all criteria and attaching notes and labs.
  2. Screening: A technician checks completeness; a pharmacist reviews the clinical details.
  3. Decision: If criteria are met, it is approved. If not, the pharmacist requests more info or recommends denial with rationale.
  4. Peer review: For complex denials, a physician reviewer evaluates. The prescriber can request a peer-to-peer discussion.
  5. Appeals: The prescriber or patient may appeal. Second-level reviews are independent. Urgent requests have faster timeframes.

Why delays happen: missing chart notes, unclear diagnosis, or lack of documented treatment failures. Complete submissions speed approvals and reduce back-and-forth.

Drug Utilization Review and Safety Programs

Beyond PAs, pharmacists run drug utilization review (DUR):

  • Prospective DUR: Real-time claim edits for high doses, interactions, or duplicate therapy.
  • Concurrent DUR: Monitoring during therapy, like opioid dose thresholds or overlapping benzodiazepines.
  • Retrospective DUR: Looking back for patterns, such as poor adherence or risky combinations, and sending targeted outreach.

They also support adherence programs for chronic diseases. Why this matters: unsafe or inconsistent use drives hospitalizations and higher costs. Preventing problems is safer and cheaper than treating them.

Specialty Pharmacy and High-Cost Therapies

Specialty drugs treat complex conditions like cancer, multiple sclerosis, or rare diseases. They often require cold-chain handling, injection training, and close monitoring. PBM pharmacists manage:

  • Site-of-care: Moving infusions to safer, lower-cost settings when appropriate.
  • Limited distribution: Coordinating with specialty pharmacies for timely delivery.
  • REMS programs: Ensuring safety requirements are met before dispensing.
  • Benefit alignment: Determining whether a drug is covered under the pharmacy or medical benefit (buy-and-bill vs specialty pharmacy).

Why the extra attention: a small number of specialty drugs drive a large share of spending, and the margin for error is small.

Rebates, Net Cost, and Guardrails

Manufacturers may offer rebates when a plan prefers their drug. Pharmacists consider net cost (price after rebates), not just list price. This can place a clinically similar drug in a preferred tier if it costs less overall.

To prevent conflicts, P&T decisions are made behind a “firewall” from rebate negotiations. Clinical value is considered first. Contracting comes after. Compliance teams audit processes, and documentation explains how evidence supported the decision. The goal is to align coverage with both patient outcomes and affordability.

Regulatory and Quality Frameworks

Rules shape pharmacist work:

  • Medicare and Medicaid requirements: Formularies must include key drug classes, follow turnaround times, and offer appeal rights.
  • Non-discrimination standards: Policies cannot unfairly block access for protected groups or conditions.
  • Quality measures: Adherence and safety metrics (like statin use in diabetes) affect plan ratings and incentives.
  • Medication therapy management (MTM): Programs target high-risk members for pharmacist review and outreach.

Why this matters: quality and regulatory oversight help ensure that cost control never overrides patient safety and fair access.

What This Looks Like Day to Day

A managed care pharmacist’s day may include:

  • Reviewing a new oncology drug: comparing survival data, side-effect rates, and net costs; drafting coverage criteria.
  • Updating step therapy for asthma after new guideline changes.
  • Answering coverage determinations and speaking with prescribers about alternatives.
  • Analyzing opioid claim data and designing a safety intervention.
  • Preparing materials for the next P&T meeting.

How to Work With PBMs: Practical Tips

For prescribers and clinic staff:

  • Use ePA tools inside the EHR when possible. They map questions to the exact drug criteria.
  • Submit complete documentation: diagnosis codes, recent labs, height/weight if dosing depends on it, and a brief treatment history with dates and outcomes.
  • Address safety checkpoints up front (e.g., trial of ACE inhibitor for heart failure unless contraindicated).
  • If the patient cannot use first-line therapy, write a short note: what happened, how severe, and why the alternative is needed now.
  • Ask for the plan’s preferred options before prescribing. Many denials stem from a non-preferred pick when a preferred equivalent exists.
  • Use peer-to-peer reviews for nuanced cases. Be ready with evidence and patient-specific risks.

For pharmacists in community or hospital settings:

  • Check formulary status at intake to avoid surprises at pickup or discharge.
  • Recommend covered alternatives when possible and offer to contact the prescriber.
  • For specialty starts, coordinate benefits and site-of-care early to prevent delays.

For patients:

  • Ask for your plan’s formulary and know your drug tiers.
  • Tell your doctor about any past side effects or treatment failures. That helps with PA approval.
  • If a drug is denied, ask about alternatives, appeal options, and financial assistance.
  • Stay adherent once you start. If cost is a barrier, share that with your care team—they can often help.

Common Misconceptions

  • “PBM pharmacists just deny drugs.” Their goal is appropriate, safe use. Approvals are common when criteria are met. Denials usually reflect missing information, non-covered use, or a safer or more cost-effective alternative.
  • “All plans have the same rules.” Criteria differ by employer, state, and benefit design. Always check the member’s specific plan.
  • “Rebates dictate everything.” Evidence and safety come first through the P&T process. Contracting happens only after clinical review.

Skills and Career Path for Managed Care Pharmacists

These roles require strong evidence appraisal, clear writing, data literacy, and policy awareness. Many pharmacists complete a managed care residency and gain experience with pharmacoeconomics, outcomes research, and quality metrics. Daily tools include drug dossiers, clinical databases, and analytics platforms. The work suits people who like big-picture impact and system-level problem solving.

Managed care pharmacists help make tough choices transparent and defensible. Through formulary design and prior authorizations, they connect science, safety, and cost into practical coverage policies. When used well, these tools protect patients, reduce waste, and keep access sustainable—while still leaving room for exceptions when a case truly needs it.

Leave a Comment